Qualcomm (NASDAQ: QCOM) shares opened about 11% down on Feb. 5 after the semiconductor giant issued cautious guidance for its fiscal Q2 that overshadowed its record-breaking performance in the holiday quarter.

In its earnings release, the company based out of San Diego, CA, cited the global memory shortage that’s forcing smartphone manufacturers to scale back production for its muted outlook.

However, it’s reasonable to assume that QCOM’s guidance will ultimately prove too conservative since its diversified portfolio and premium focus position it well to weather supply constraints.

In fact, the post-earnings sell-off may actually be an “exciting opportunity” for long-term investors to invest in Qualcomm stock that’s now down more than 25% versus its year-to-date high.

Why memory shortage may not be ‘that’ big a concern for QCOM shares

QCOM stock’s post-earnings plunge may be “overdone” given the market is treating the memory shortage as a demand problem, when it’s actually a logistical delay only.

On the earnings call, the company’s chief executive, Cristiano Amon, agreed that consumer demand for high-end phones remains robust.

The “weakness” is simply OEMs being unable to finish building phones they have already planned. This is “deferred” revenue – not lost sales.

Additionally, the shortage hits low-end, low-margin budget phones the hardest because they can’t absorb the DRAM price hikes – but Qualcomm’s bread and butter is the premium tier (Snapdragon 8 Series).

High-end consumers are less price-sensitive, and OEMs will prioritise their limited memory supply for these high-margin flagship devices where QCOM makes its biggest profits.

In short, while memory shortage sure is a headwind, it’s not like Qualcomm is entirely unequipped to weather that storm.

How diversified portfolio makes Qualcomm stock worth owning on the dip

What’s also worth mentioning is that even if memory shortages cap handset shipments through the remainder of 2026, QCOM’s diversified portfolio positions its stock well to remain resilient.

Amid smartphone weakness, Qualcomm will continue reallocating resources aggressively toward its Automotive and PC (Snapdragon X) divisions – which rely on different supply chains and are currently growing at record rates.

The strategy is already yielding results: Automotive revenue reached a record “$1.1 billion” in the company’s first quarter, growing about 15% on a year-over-year basis.

On Thursday, the management even guided for Automotive growth to surpass 35% in fiscal Q2 – reinforcing that this segment offers higher long-term visibility.

By leveraging the “Snapdragon Digital Chassis” for partners like Volkswagen and Toyota, and scaling the Snapdragon X2 Plus for a new wave of 150+ artificial intelligence PCs, QCOM is transforming into a diversified processing giant.

This shift effectively “de-risks” the portfolio – turning a temporary smartphone supply cap into a catalyst for its more profitable, high-growth “beyond-mobile” future.

All in all, it’s no longer just a smartphone company; it’s an Edge AI and computing powerhouse, and that makes Qualcomm shares worth buying at the current toned down levels.  

The post Qualcomm stock: why the ‘memory problem’ may be overstated appeared first on Invezz

BigBear.ai (NYSE: BBAI stock) tumbled roughly 6% on Wednesday, extending losses that reflect a blend of company-specific headwinds and broader AI sector volatility.

The sell-off stems from worries around the upcoming shareholder vote to roughly double authorized shares and the January redemption of $125 million in convertible notes that triggered 38 million new share issuances.

Moreover, the persistent uncertainty around government contract timing and revenue growth is also weighing on the sentiment.

For a small-cap AI stock trading with a beta of 3.2, sector-wide de-risking amplifies selling pressure on fundamentals that were already fragile.​

BBAI stock: Investors worried about dilution trap

On December 1, 2025, BigBear.ai shareholders approved an amendment to increase authorized common stock from 500 million to 1 billion shares.

The management characterized the move as enabling future flexibility for financing, equity awards, and potential acquisitions.

While the vote passed (191.6 million shares for, 44.5 million against), investors remain on edge because authorized share capacity does not immediately dilute holdings, but signals the company’s willingness to tap equity financing down the road.​

The more immediate worries are around BigBear.ai’s plan redeem all outstanding $125 million in convertible notes due 2029.

Rather than redeem for cash, the company offered noteholders the option to convert into common stock at 305.53 shares per $1,000 principal.

As a result, approximately 38 million new shares were issued.

The math is bothering investors as the company had roughly 435.8 million shares outstanding as of September 2025; the 38 million shares from note conversions alone represent an 8.7% dilution to existing shareholders.​

Sector weakness compounds pain

BigBear.ai’s 6% drop cannot be divorced from the broader AI market rout.

On February 3–4, the S&P 500 slipped 0.3% as investors rotated away from expensive technology and semiconductor names after AMD’s cautious Q1 guidance and Broadcom’s margin warnings.

For a stock with a high beta and a small market cap of roughly $2.16 billion, sector momentum swings hit harder.

Analyst commentary underscores the tension.

Wall Street consensus remains “Hold” with a price target of $6.00, though opinions vary sharply.

Cantor Fitzgerald downgraded to neutral in early January, citing dilution concerns and slowing revenue growth.

HC Wainwright maintains a “Buy” at $8.00, but Weiss Ratings has flagged the stock as “Sell,” pointing to negative margins, declining revenue.

Revenue and contract timing questions linger

Beyond the dilution arithmetic, investors are wrestling with whether BigBear.ai can sustain revenue growth amid government spending delays.

The company boasts a strong government backlog of $418 million and recent DoD contract wins (including a $13.2 million ORION force-management deal), but historical restatements and delayed 10-K filings in 2025 have eroded confidence.

The February 18 shareholder meeting to finalize the authorized share increase now looms as a key event.

For now, traders are parsing the trade-off as management claims the higher authorized ceiling provides strategic optionality.

But investors seem worried that it signals future aggressive equity raises to fund operations without sacrificing debt.

The post Why is BBAI stock plunging more than 6% today? appeared first on Invezz

Tilray Brands stock price continued its strong downward trend, reaching its lowest level since December 9 last year. It has crashed by over 68% from its highest level in October last year. 

Why Tilray Brands stock price has crashed 

Tilray Brands and other cannabis stocks have plunged in the past few months. The closely-watched AdvisorShares Pure US Cannabis (MSOS) ETF stock has retreated from a high of $7.25 in December to the current $4.10.

Tilray Brands and these cannabis stocks have plunged in the past few months as investors sold the cannabis rescheduling news that broke last year, when Donald Trump asked Attorney General Pam Bondi to reschedule it from a Schedule 1 to a Schedule 3 drug.

Therefore, Tilray Brands stock price has crashed because Bondi has not made any step towards rescheduling. Also, the whole rescheduling process will take more months or years to complete.

Additionally, rescheduling itself will not be enough to incentivize companies like Tilray Brands, which face some major challenges, including in the banking sector.

Tilray Brands business is facing major challenges 

The most recent results showed that the Tilray Brands business is struggling. Data shows that its revenue rose by 3% in the second quarter to $217 million.

However, the company’s gross profit dropped to $57.5 million from the previous $61.2 million. A closer look at its business shows that its cannabis revenue rose to $65.7 million from the previous $65.7 million, helped by its international business.

The revenue growth was also driven by its distribution revenue rose to $85.3 million from the previous $67.6 million. This growth has made it the biggest segment in its business.

However, the company’s beverage business, which the company has spent years boosting, continues to deteriorate. Its revenue dropped to $50 million from the previous $63 million, while its wellness segment was flat at $14.6 million.

The results also showed that Tilray Brands improved its bottomline, with the net loss moving to $41.8 million from $43.5 million.

Analysts are optimistic that Tilray Brands’ business will continue experiencing single-digit revenue growth. The average estimate is that its revenue for the current quarter will be $201 million, up by 8.4% from the same period a year earlier.

Its annual revenue is expected to move to $865 million, up by 5.38% YoY, followed by $906 million in the coming financial year.

Tilray stock price technical analysis

The daily timeframe chart shows that the TLRY stock price has crashed in the past few months, moving from a high of $15.75 in December to the current $7.45. This crash was in line with our last Tilray forecast.

It has now moved below the 78.6% Fibonacci Retracement level at $7.73. Also, the stock has moved below the Weak, Stop, & Reverse level of the Murrey Math Lines tool at $7.8.

The stock has moved below the 50-day and 100-day Exponential Moving Averages (EMA), while the Relative Strength Index (RSI$ has moved close to the oversold level.

There are signs that the stock is slowly forming a double-bottom pattern at $7, its lowest level in December last year and a neckline at $15.

Therefore, the stock will likely rebound in the coming weeks. If this happens, the next key resistance level to watch will be the Major S&R Pivot Point at $12.5.

Historically, the stock is usually highly volatile, meaning that such a rebound will lead to a pullback.

The post Tilray Brands stock has crashed—but a bullish pattern is emerging appeared first on Invezz

Advanced Micro Devices’ stock surged more than 5% on Monday as investors positioned ahead of the semiconductor company’s quarterly earnings report, due after the market closes on Tuesday.

The rally reflects growing optimism that momentum in data-centre processors and artificial intelligence chips will continue, even as the broader chip sector navigates supply constraints and uneven demand signals.

AMD shares have outperformed in recent sessions as anticipation builds around whether the company can extend a run of solid execution and market-share gains, particularly in servers.

Earnings expectations set a high bar

Wall Street is forecasting another strong quarter from AMD. Analysts expect revenue of roughly $9.67 billion for the December period, representing growth of about 27% from a year earlier.

Adjusted earnings are projected at around $1.32 per share.

Those expectations follow a robust prior quarter, when AMD beat revenue estimates by about 5.6% and reported sales of $9.25 billion.

That performance reinforced confidence in the company’s exposure to cloud and enterprise customers, even as consumer PC demand remained more mixed.

During its third-quarter earnings call, Chief Financial Officer Jean Hu said the company’s fourth-quarter revenue outlook of approximately $9.6 billion, plus or minus $300 million, excludes revenue from shipments of its Instinct MI308 accelerators to China.

That disclosure highlighted the degree to which geopolitical and regulatory factors continue to shape AMD’s near-term revenue profile, particularly in advanced AI hardware.

Analysts see upside, but limits remain

RBC Capital Markets has reiterated its Sector Perform rating and $230 price target on AMD ahead of the earnings release.

Analyst Srini Pajjuri expects the company to beat consensus estimates and raise guidance, supported by healthy server demand and continued market-share gains in central processing units.

RBC anticipates that management will reaffirm previously communicated timelines for ramping its MI455 and Helios AI accelerators.

The firm said recent concerns around wafer supply constraints and execution risks tied to rack-scale systems are unlikely to derail those plans in the near term.

At the same time, RBC noted that AMD management appears confident about securing the initial gigawatt-scale opportunity with OpenAI, which the firm believes is already embedded in its financial models.

However, RBC cautioned that additional near-term upside from AI accelerators could be constrained by supply limitations, suggesting that expectations beyond current guidance may need to be tempered.

Cantor Fitzgerald has taken a more bullish stance, reiterating its Overweight rating and $350 price target on AMD, according to a report cited by Investing.com.

The firm expects AMD to deliver a modest beat for the December quarter and raise guidance for the March period.

Cantor Fitzgerald contrasted AMD’s outlook with Intel’s recent results, noting that AMD is not facing the same wafer transition challenges in its client and server products that weighed on Intel’s guidance.

That relative positioning has helped fuel investor confidence that AMD can continue to execute smoothly while competitors navigate internal and external headwinds.

The post AMD stock surges over 5% ahead of Q4 earnings: what to expect appeared first on Invezz

The Schwab US Dividend Equity ETF (SCHD) is doing well this year and is constantly beating the broader market, including the S&P 500 and the Nasdaq 100 indices. 

SCHD has jumped by 8.50% this year and is now hovering at its all-time high, while the S&P 500 has risen by just 1%. This article explores the main reason why the SCHD ETF is thriving this year.

SCHD ETF is thriving as rotation from AI companies continue 

The SCHD ETF is firing on all cylinders this year and is up by nearly 30% from its lowest level in April last year. 

The main reason behind the rally is the ongoing rotation from technology stocks to value names.

A closer look shows that most technological stocks have crashed and moved into either a correction or a bear market.

NVIDIA, a top player in the AI industry, has dropped by 10% from its highest level in 2025. Similarly, Microsoft stock has plummeted to $430, down by 22% from its all-time high.

Other software companies, including popular names like Palantir, ServiceNow, Intuit, and Salesforce, have all crashed.

On the other hand, investors have turned to other value companies that have underperformed the broader market in the past few months.

Soaring energy prices have boosted the SCHD stock 

The other main reason behind the ongoing SCHD stock rally is the energy sector. Data shows that the energy segment is the biggest part of the index, with companies in the industry accounting for 20% of the fund.

Energy stocks have jumped in the past few months as crude oil has soared. Brent, the global benchmark, rose to $70 as the risk that the United States will attack Iran rose. 

Data shows that the State Street Energy Select Sector ETF (XLE) jumped to a high of $51, up by 40% from its lowest level in April last year. The ETF has jumped to a record high.

Some of the top energy stocks in the SCHD ETF are Chevron, ConocoPhillips, EOG Resources, and Valero Energy.

Corporate earnings to impact its performance 

The SCHD ETF stock will have some notable catalysts this week. The most important one will be key corporate earnings, including top companies like Palantir, Walt Disney, AMD, Merck, Amgen, Pfizer, Alphabet, Eli Lilly, AbbVie, Qualcomm, Boston Scientific, ConocoPhilips, Bristol-Myers Squibb, ICE, Philip Morris, and Biogen.

These companies will publish their earnings, which will provide more information about their performance in the fourth quarter. Analysts expect the report to show that these companies continued doing well in the quarter.

The other potential catalysts for the SCHD ETF this week will be the upcoming US non-farm payrolls data, which will come out on Friday. It will also react to the decision by Donald Trump to nominate Kevin Warsh as the next Federal Reserve Chair.

SCHD ETF stock technical analysis 

The daily timeframe chart shows that the SCHD ETF stock has been in a strong uptrend in the past few months. It jumped from a low of $23.20 in April last year to the current $29.82.

The fund has remained constantly above the 50-day and 100-day Exponential Moving Averages (EMA). It also moved above the Supertrend indicator and the Ichimoku cloud.

The Average Directional Index (ADX) has jumped to 43, its highest level in over a year, and much higher than last year’s low of 9.68. A soaring ADX indicator is a sign that the momentum is growing.

Therefore, the most likely scenario is where it continues rising as bulls target the next key resistance level at $35. A drop below the key support at $28 will invalidate the bullish outlook.

The post SCHD ETF stock is beating the S&P 500 and Nasdaq 100 this year appeared first on Invezz